A citation-based method for searching scientific literature

Padma Kadiyala, Stephen V Carney, Jessica C Gauss, Maria B Garcia-Fabiani, Santiago Haase, Mahmoud S Alghamri, Felipe J Núñez, Yayuan Liu, Minzhi Yu, Ayman Taher, Fernando M Nunez, Dan Li, Marta B Edwards, Celina G Kleer, Henry Appelman, Yilun Sun, Lili Zhao, James J Moon, Anna Schwendeman, Pedro R Lowenstein, Maria G Castro. J Clin Invest 2021
Times Cited: 11







List of co-cited articles
133 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Mutant IDH1 regulates the tumor-associated immune system in gliomas.
Nduka M Amankulor, Youngmi Kim, Sonali Arora, Julia Kargl, Frank Szulzewsky, Mark Hanke, Daciana H Margineantu, Aparna Rao, Hamid Bolouri, Jeff Delrow,[...]. Genes Dev 2017
180
63

Suppression of antitumor T cell immunity by the oncometabolite (R)-2-hydroxyglutarate.
Lukas Bunse, Stefan Pusch, Theresa Bunse, Felix Sahm, Khwab Sanghvi, Mirco Friedrich, Dalia Alansary, Jana K Sonner, Edward Green, Katrin Deumelandt,[...]. Nat Med 2018
137
63

Isocitrate dehydrogenase mutations suppress STAT1 and CD8+ T cell accumulation in gliomas.
Gary Kohanbash, Diego A Carrera, Shruti Shrivastav, Brian J Ahn, Naznin Jahan, Tali Mazor, Zinal S Chheda, Kira M Downey, Payal B Watchmaker, Casey Beppler,[...]. J Clin Invest 2017
167
63

A vaccine targeting mutant IDH1 in newly diagnosed glioma.
Michael Platten, Lukas Bunse, Antje Wick, Theresa Bunse, Lucian Le Cornet, Inga Harting, Felix Sahm, Khwab Sanghvi, Chin Leng Tan, Isabel Poschke,[...]. Nature 2021
34
54

The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary.
David N Louis, Arie Perry, Guido Reifenberger, Andreas von Deimling, Dominique Figarella-Branger, Webster K Cavenee, Hiroko Ohgaki, Otmar D Wiestler, Paul Kleihues, David W Ellison. Acta Neuropathol 2016
45

Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1.
Roel G W Verhaak, Katherine A Hoadley, Elizabeth Purdom, Victoria Wang, Yuan Qi, Matthew D Wilkerson, C Ryan Miller, Li Ding, Todd Golub, Jill P Mesirov,[...]. Cancer Cell 2010
45

Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma.
Michele Ceccarelli, Floris P Barthel, Tathiane M Malta, Thais S Sabedot, Sofie R Salama, Bradley A Murray, Olena Morozova, Yulia Newton, Amie Radenbaugh, Stefano M Pagnotta,[...]. Cell 2016
977
45

Correlation of immune phenotype with IDH mutation in diffuse glioma.
Anna Sophie Berghoff, Barbara Kiesel, Georg Widhalm, Dorothee Wilhelm, Orsolya Rajky, Sebastian Kurscheid, Philip Kresl, Adelheid Wöhrer, Christine Marosi, Monika E Hegi,[...]. Neuro Oncol 2017
127
45

IDH1 and IDH2 mutations in gliomas.
Hai Yan, D Williams Parsons, Genglin Jin, Roger McLendon, B Ahmed Rasheed, Weishi Yuan, Ivan Kos, Ines Batinic-Haberle, Siân Jones, Gregory J Riggins,[...]. N Engl J Med 2009
36

Efficient induction of differentiation and growth inhibition in IDH1 mutant glioma cells by the DNMT Inhibitor Decitabine.
Sevin Turcan, Armida W M Fabius, Alexandra Borodovsky, Alicia Pedraza, Cameron Brennan, Jason Huse, Agnes Viale, Gregory J Riggins, Timothy A Chan. Oncotarget 2013
145
36

IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype.
Sevin Turcan, Daniel Rohle, Anuj Goenka, Logan A Walsh, Fang Fang, Emrullah Yilmaz, Carl Campos, Armida W M Fabius, Chao Lu, Patrick S Ward,[...]. Nature 2012
36

IDH mutation impairs histone demethylation and results in a block to cell differentiation.
Chao Lu, Patrick S Ward, Gurpreet S Kapoor, Dan Rohle, Sevin Turcan, Omar Abdel-Wahab, Christopher R Edwards, Raya Khanin, Maria E Figueroa, Ari Melnick,[...]. Nature 2012
36

Interrogation of the Microenvironmental Landscape in Brain Tumors Reveals Disease-Specific Alterations of Immune Cells.
Florian Klemm, Roeltje R Maas, Robert L Bowman, Mara Kornete, Klara Soukup, Sina Nassiri, Jean-Philippe Brouland, Christine A Iacobuzio-Donahue, Cameron Brennan, Viviane Tabar,[...]. Cell 2020
137
36

Single-Cell Mapping of Human Brain Cancer Reveals Tumor-Specific Instruction of Tissue-Invading Leukocytes.
Ekaterina Friebel, Konstantina Kapolou, Susanne Unger, Nicolás Gonzalo Núñez, Sebastian Utz, Elisabeth Jane Rushing, Luca Regli, Michael Weller, Melanie Greter, Sonia Tugues,[...]. Cell 2020
108
36

Immunosuppressive Myeloid Cells' Blockade in the Glioma Microenvironment Enhances the Efficacy of Immune-Stimulatory Gene Therapy.
Neha Kamran, Padma Kadiyala, Meghna Saxena, Marianela Candolfi, Youping Li, Mariela A Moreno-Ayala, Nicholas Raja, Diana Shah, Pedro R Lowenstein, Maria G Castro. Mol Ther 2017
71
27

Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy.
Christine E Brown, Darya Alizadeh, Renate Starr, Lihong Weng, Jamie R Wagner, Araceli Naranjo, Julie R Ostberg, M Suzette Blanchard, Julie Kilpatrick, Jennifer Simpson,[...]. N Engl J Med 2016
710
27

Immunotherapy for gliomas: shedding light on progress in preclinical and clinical development.
Maria B Garcia-Fabiani, Maria Ventosa, Andrea Comba, Marianela Candolfi, Alejandro J Nicola Candia, Mahmoud S Alghamri, Padma Kadiyala, Stephen Carney, Syed M Faisal, Anna Schwendeman,[...]. Expert Opin Investig Drugs 2020
5
60

ATRX loss promotes tumor growth and impairs nonhomologous end joining DNA repair in glioma.
Carl Koschmann, Anda-Alexandra Calinescu, Felipe J Nunez, Alan Mackay, Janet Fazal-Salom, Daniel Thomas, Flor Mendez, Neha Kamran, Marta Dzaman, Lakshman Mulpuri,[...]. Sci Transl Med 2016
127
27

Current state and future prospects of immunotherapy for glioma.
Neha Kamran, Mahmoud S Alghamri, Felipe J Nunez, Diana Shah, Antonela S Asad, Marianela Candolfi, David Altshuler, Pedro R Lowenstein, Maria G Castro. Immunotherapy 2018
29
27

Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma.
Houtan Noushmehr, Daniel J Weisenberger, Kristin Diefes, Heidi S Phillips, Kanan Pujara, Benjamin P Berman, Fei Pan, Christopher E Pelloski, Erik P Sulman, Krishna P Bhat,[...]. Cancer Cell 2010
27

Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma.
Dominik Sturm, Hendrik Witt, Volker Hovestadt, Dong-Anh Khuong-Quang, David T W Jones, Carolin Konermann, Elke Pfaff, Martje Tönjes, Martin Sill, Sebastian Bender,[...]. Cancer Cell 2012
27

Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas.
Christian Hartmann, Jochen Meyer, Jörg Balss, David Capper, Wolf Mueller, Arne Christians, Jörg Felsberg, Marietta Wolter, Christian Mawrin, Wolfgang Wick,[...]. Acta Neuropathol 2009
776
27

A vaccine targeting mutant IDH1 induces antitumour immunity.
Theresa Schumacher, Lukas Bunse, Stefan Pusch, Felix Sahm, Benedikt Wiestler, Jasmin Quandt, Oliver Menn, Matthias Osswald, Iris Oezen, Martina Ott,[...]. Nature 2014
395
27

Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas.
Daniel J Brat, Roel G W Verhaak, Kenneth D Aldape, W K Alfred Yung, Sofie R Salama, Lee A D Cooper, Esther Rheinbay, C Ryan Miller, Mark Vitucci, Olena Morozova,[...]. N Engl J Med 2015
27

An integrated genomic analysis of human glioblastoma multiforme.
D Williams Parsons, Siân Jones, Xiaosong Zhang, Jimmy Cheng-Ho Lin, Rebecca J Leary, Philipp Angenendt, Parminder Mankoo, Hannah Carter, I-Mei Siu, Gary L Gallia,[...]. Science 2008
27

5-azacytidine reduces methylation, promotes differentiation and induces tumor regression in a patient-derived IDH1 mutant glioma xenograft.
Alexandra Borodovsky, Vafi Salmasi, Sevin Turcan, Armida W M Fabius, Gilson S Baia, Charles G Eberhart, Jon D Weingart, Gary L Gallia, Stephen B Baylin, Timothy A Chan,[...]. Oncotarget 2013
103
27

Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation.
Maria E Figueroa, Omar Abdel-Wahab, Chao Lu, Patrick S Ward, Jay Patel, Alan Shih, Yushan Li, Neha Bhagwat, Aparna Vasanthakumar, Hugo F Fernandez,[...]. Cancer Cell 2010
27

The IDH1 Mutation-Induced Oncometabolite, 2-Hydroxyglutarate, May Affect DNA Methylation and Expression of PD-L1 in Gliomas.
Luyan Mu, Yu Long, Changlin Yang, Linchun Jin, Haipeng Tao, Haitao Ge, Yifan E Chang, Aida Karachi, Paul S Kubilis, Gabriel De Leon,[...]. Front Mol Neurosci 2018
29
27

Proximity ligation assay evaluates IDH1R132H presentation in gliomas.
Lukas Bunse, Theresa Schumacher, Felix Sahm, Stefan Pusch, Iris Oezen, Katharina Rauschenbach, Marina Gonzalez, Gergely Solecki, Matthias Osswald, David Capper,[...]. J Clin Invest 2015
26
27

Signatures of mutational processes in human cancer.
Ludmil B Alexandrov, Serena Nik-Zainal, David C Wedge, Samuel A J R Aparicio, Sam Behjati, Andrew V Biankin, Graham R Bignell, Niccolò Bolli, Ake Borg, Anne-Lise Børresen-Dale,[...]. Nature 2013
27

Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of α-ketoglutarate-dependent dioxygenases.
Wei Xu, Hui Yang, Ying Liu, Ying Yang, Ping Wang, Se-Hee Kim, Shinsuke Ito, Chen Yang, Pu Wang, Meng-Tao Xiao,[...]. Cancer Cell 2011
27

EGFRvIII mCAR-modified T-cell therapy cures mice with established intracerebral glioma and generates host immunity against tumor-antigen loss.
John H Sampson, Bryan D Choi, Luis Sanchez-Perez, Carter M Suryadevara, David J Snyder, Catherine T Flores, Robert J Schmittling, Smita K Nair, Elizabeth A Reap, Pamela K Norberg,[...]. Clin Cancer Res 2014
177
27

Heterogeneity of response to immune checkpoint blockade in hypermutated experimental gliomas.
Katrin Aslan, Verena Turco, Jens Blobner, Jana K Sonner, Anna Rita Liuzzi, Nicolás Gonzalo Núñez, Donatella De Feo, Philipp Kickingereder, Manuel Fischer, Ed Green,[...]. Nat Commun 2020
49
27

Effective immuno-targeting of the IDH1 mutation R132H in a murine model of intracranial glioma.
Serena Pellegatta, Lorella Valletta, Cristina Corbetta, Monica Patanè, Ileana Zucca, Federico Riccardi Sirtori, Maria Grazia Bruzzone, Gianpaolo Fogliatto, Antonella Isacchi, Bianca Pollo,[...]. Acta Neuropathol Commun 2015
62
27

Immune suppression in gliomas.
Matthew M Grabowski, Eric W Sankey, Katherine J Ryan, Pakawat Chongsathidkiet, Selena J Lorrey, Daniel S Wilkinson, Peter E Fecci. J Neurooncol 2021
34
18


IDO expression in brain tumors increases the recruitment of regulatory T cells and negatively impacts survival.
Derek A Wainwright, Irina V Balyasnikova, Alan L Chang, Atique U Ahmed, Kyung-Sub Moon, Brenda Auffinger, Alex L Tobias, Yu Han, Maciej S Lesniak. Clin Cancer Res 2012
235
18

Neoadjuvant nivolumab modifies the tumor immune microenvironment in resectable glioblastoma.
Kurt A Schalper, Maria E Rodriguez-Ruiz, Ricardo Diez-Valle, Alvaro López-Janeiro, Angelo Porciuncula, Miguel A Idoate, Susana Inogés, Carlos de Andrea, Ascensión López-Diaz de Cerio, Sonia Tejada,[...]. Nat Med 2019
217
18

IDH1 and IDH2 mutations are prognostic but not predictive for outcome in anaplastic oligodendroglial tumors: a report of the European Organization for Research and Treatment of Cancer Brain Tumor Group.
Martin J van den Bent, Hendrikus J Dubbink, Yannick Marie, Alba A Brandes, Martin J B Taphoorn, Pieter Wesseling, Marc Frenay, Cees C Tijssen, Denis Lacombe, Ahmed Idbaih,[...]. Clin Cancer Res 2010
305
18

What is immune privilege (not)?
Ian Galea, Ingo Bechmann, V Hugh Perry. Trends Immunol 2007
474
18

CCL2 Produced by the Glioma Microenvironment Is Essential for the Recruitment of Regulatory T Cells and Myeloid-Derived Suppressor Cells.
Alan L Chang, Jason Miska, Derek A Wainwright, Mahua Dey, Claudia V Rivetta, Dou Yu, Deepak Kanojia, Katarzyna C Pituch, Jian Qiao, Peter Pytel,[...]. Cancer Res 2016
262
18

Genetic and molecular epidemiology of adult diffuse glioma.
Annette M Molinaro, Jennie W Taylor, John K Wiencke, Margaret R Wrensch. Nat Rev Neurol 2019
149
18

Macrophage Exclusion after Radiation Therapy (MERT): A First in Human Phase I/II Trial using a CXCR4 Inhibitor in Glioblastoma.
Reena P Thomas, Seema Nagpal, Michael Iv, Scott G Soltys, Sophie Bertrand, Judith S Pelpola, Robyn Ball, Jaden Yang, Vandana Sundaram, Jonathan Lavezo,[...]. Clin Cancer Res 2019
32
18


Synthetic High-density Lipoprotein Nanodiscs for Personalized Immunotherapy Against Gliomas.
Lindsay Scheetz, Padma Kadiyala, Xiaoqi Sun, Sejin Son, Alireza Hassani Najafabadi, Marisa Aikins, Pedro R Lowenstein, Anna Schwendeman, Maria G Castro, James J Moon. Clin Cancer Res 2020
17
18


Immune Microenvironment in Glioblastoma Subtypes.
Zhihong Chen, Dolores Hambardzumyan. Front Immunol 2018
126
18

Hemispherical Pediatric High-Grade Glioma: Molecular Basis and Therapeutic Opportunities.
Santiago Haase, Fernando M Nuñez, Jessica C Gauss, Sarah Thompson, Emily Brumley, Pedro Lowenstein, Maria G Castro. Int J Mol Sci 2020
5
40

Combined immunostimulation and conditional cytotoxic gene therapy provide long-term survival in a large glioma model.
Sumia Ali, Gwendalyn D King, James F Curtin, Marianela Candolfi, Weidong Xiong, Chunyan Liu, Mariana Puntel, Queng Cheng, Jesus Prieto, Antoni Ribas,[...]. Cancer Res 2005
95
18

HMGB1 mediates endogenous TLR2 activation and brain tumor regression.
James F Curtin, Naiyou Liu, Marianela Candolfi, Weidong Xiong, Hikmat Assi, Kader Yagiz, Matthew R Edwards, Kathrin S Michelsen, Kurt M Kroeger, Chunyan Liu,[...]. PLoS Med 2009
257
18


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.